Effectiveness and Overall Safety of NutropinAq® for Growth Hormone Deficiency and Other Paediatric Growth Hormone Disorders: Completion of the International Cooperative Growth Study, NutropinAq® European Registry (iNCGS)

Effectiveness and Overall Safety of NutropinAq® for Growth Hormone Deficiency and Other Paediatric Growth Hormone Disorders: Completion of the International Cooperative Growth Study, NutropinAq® European Registry (iNCGS)

ObjectiveThe International Cooperative Growth Study, NutropinAq® European Registry (iNCGS) (NCT00455728) monitored long-term safety and effectiveness of recombinant human growth hormone (rhGH; NutropinAq® [somatropin]) in paediatric growth disorders.MethodsOpen-label, non-interventional, post-market...

Full description

Bibliographic Details
Main Authors: Regis Coutant, Jordi Bosch Muñoz, Cristina Patricia Dumitrescu, Dirk Schnabel, Caroline Sert, Valerie Perrot, Mehul Dattani
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Endocrinology
Subjects:
NutropinAq® (somatropin)
rhGH, recombinant human GH
growth hormone deficiency
paediatric GH disorders
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.676083/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2021.676083/full

Similar Items